TY - JOUR
T1 - Differential expression of normal and mutant Huntington's disease gene alleles
AU - Persichetti, Francesca
AU - Carlee, Leone
AU - Faber, Peter W.
AU - McNeil, Sandra M.
AU - Ambrose, Christine M.
AU - Srinidhi, Jayalakshmi
AU - Anderson, Mary Anne
AU - Barnes, Glenn T.
AU - Gusella, James F.
AU - MacDonald, Marcy E.
N1 - Funding Information:
We thank Drs. Alan Dodge and Andrew Read for originally providing the CV066 cell line. This work was supported by NIH Grants NS16367 and NS32765 and by grants from Bristol–Myers Squibb, Inc., the Hereditary Disease Foundation, and the Huntington’s Disease Society of America. C.M.A. was supported by the Andrew B. Cogan Fellowship of the Hereditary Disease Foundation, S.M.M. was supported by a fellowship from the Huntington’s Disease Society of America, and P.W.F. received a fellowship from the Human Frontiers Program.
PY - 1996/6
Y1 - 1996/6
N2 - Huntingtin expression was examined by Western blot and immunoprecipitation studies of lymphoblastoid cell lines from Huntington's disease (HD) homozygotes, heterozygotes, and a phenotypically normal individual with a t(4p16.3;12p13.3) breakpoint in the HD gene. The latter produced a reduced level of normal huntingtin without evidence of an altered protein, indicating that simple loss of huntingtin activity does not cause HD. In juvenile onset HD heterozygotes, NH2- and COOH-terminal antisera revealed reduced relative expression from the mutant allele. Pulse-chase studies indicated that huntingtin is a stable protein whose differential allelic expression is not due to destabilization of the mutant isoform. No stable breakdown products specific to mutant huntingtin were detected in either HD homozygotes or heterozygotes. These data are consistent with HD involving either a gain of function or a dominant negative loss of function that operates within severe constraints and suggest that in either case the pathogenic process is usually saturated by the amount of abnormal huntingtin produced from a single mutant allele.
AB - Huntingtin expression was examined by Western blot and immunoprecipitation studies of lymphoblastoid cell lines from Huntington's disease (HD) homozygotes, heterozygotes, and a phenotypically normal individual with a t(4p16.3;12p13.3) breakpoint in the HD gene. The latter produced a reduced level of normal huntingtin without evidence of an altered protein, indicating that simple loss of huntingtin activity does not cause HD. In juvenile onset HD heterozygotes, NH2- and COOH-terminal antisera revealed reduced relative expression from the mutant allele. Pulse-chase studies indicated that huntingtin is a stable protein whose differential allelic expression is not due to destabilization of the mutant isoform. No stable breakdown products specific to mutant huntingtin were detected in either HD homozygotes or heterozygotes. These data are consistent with HD involving either a gain of function or a dominant negative loss of function that operates within severe constraints and suggest that in either case the pathogenic process is usually saturated by the amount of abnormal huntingtin produced from a single mutant allele.
UR - http://www.scopus.com/inward/record.url?scp=0030175161&partnerID=8YFLogxK
U2 - 10.1006/nbdi.1996.0018
DO - 10.1006/nbdi.1996.0018
M3 - Article
SN - 0969-9961
VL - 3
SP - 183
EP - 190
JO - Neurobiology of Disease
JF - Neurobiology of Disease
IS - 3
ER -